Physician profile
Michael E Champion
NPI 1558364018
$2,243.37
in general payments reported to CMS, 2019-2025
16 companies · $910 in 2025
The $910 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $98.68 · 2022: $217 · 2023: $377 · 2024: $640 · 2025: $910.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,927.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $352.33 | 2023-2025 | Otezla, Krystexxa |
| Teva Pharmaceuticals USA, INC. | $259.98 | 2024-2025 | Austedo Xr |
| Abbott Laboratories | $204.59 | 2022-2024 | Freestyle Libre 3 |
| Globus Medical, INC. | $173.83 | 2025 | Senza |
| Pfizer INC. | $147.83 | 2024-2025 | |
| Kerecis Limited | $145.70 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Inari Medical, INC. | $132.26 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stemline Therapeutics INC. | $121.82 | 2022 | |
| Gilead Sciences, INC. | $118.33 | 2024 | Epclusa |
| Sanofi US Services INC. | $103.69 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $100.01 | 2023 | Fasenra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.93 | 2025 | Xifaxan |
| Si-Bone, INC. | $98.68 | 2021 | |
| Phadia US INC. | $81.55 | 2025 | Immunocap |
| Janssen Pharmaceuticals, INC | $57.70 | 2024 | Spravato |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $45.14 | 2024 | Evarrest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Champion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.